1
|
Abbas AA, Dawood KM. Anticancer therapeutic potential of benzofuran scaffolds. RSC Adv 2023; 13:11096-11120. [PMID: 37056966 PMCID: PMC10086673 DOI: 10.1039/d3ra01383a] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Accepted: 03/31/2023] [Indexed: 04/15/2023] Open
Abstract
Benzofuran moiety is the main component of many biologically active natural and synthetic heterocycles. These heterocycles have unique therapeutic potentials and are involved in various clinical drugs. The reported results confirmed the extraordinary inhibitory potency of such benzofurans against a panel of human cancer cell lines compared with a wide array of reference anticancer drugs. Several publications about the anticancer potencies of benzofuran-based heterocycles were encountered. The recent developments of anticancer activities of both natural and synthetic benzofuran scaffolds during 2019-2022 are thoroughly covered. Many of the described benzofurans are promising candidates for development as anticancer agents based on their outstanding inhibitory potency against a panel of human cancer cells compared with reference anticancer drugs. These findings encourage medicinal chemists to explore new areas to improve human health and reduce suffering.
Collapse
Affiliation(s)
- Ashraf A Abbas
- Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt +20-2-35727556 +20-2-35676602
| | - Kamal M Dawood
- Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt +20-2-35727556 +20-2-35676602
| |
Collapse
|
2
|
Ma LX, Shi Y, Li JL, Guo Q, Zhou ZX, Huang ZY. Synthesis, Crystal Structure, and DFT Study of Ethyl 3-(2,3-Dihydrobenzofuran-5-yl)-2-propenoate. RUSS J GEN CHEM+ 2022. [DOI: 10.1134/s1070363222120416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
|
3
|
Liu Y, Xiang Q, Liang Q, Shi J, He J. Genus Spatholobus: a comprehensive review on ethnopharmacology, phytochemistry, pharmacology, and toxicology. Food Funct 2022; 13:7448-7472. [PMID: 35766524 DOI: 10.1039/d2fo00895e] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Edible medicinal plants are important sources for the development of health beneficial products and drugs. Several species of the genus Spatholobus are considered as medicinal and food homologous plants in various Asian countries for the treatment of menstrual pain, anemia, paralysis, arthralgia, etc. Regarding this genus, mounting investigations on different aspects have been conducted; however, a comprehensive review about these findings is yet to be compiled. Herein, we reviewed the up-to-date information on the botanical description, distribution, ethnopharmacology, phytochemistry, pharmacology, and toxicology of the Spatholobus species for the first time to support their development potential. Thus far, 175 phytochemicals have been isolated, and flavonoids are the predominant constituents. Furthermore, 141 compounds show the ideal characteristic behavior of a drug-like molecule. Besides, the compounds and crude extracts of this genus have been demonstrated to exert a wide range of in vitro and in vivo bioactivities, such as antitumor activity, antioxidant activity, antiinflammatory activity, antiischemic activity, antimicrobial activity, and neuroprotective activity. Toxicity studies have revealed that Spatholobus species seem to have no apparent toxic effects. Even so, the need for in-depth studies to reveal the scientific connotation of the widely documented traditional actions, the structure-activity relationship of the bioactive compounds, and the systematic toxic reactions are warranted, and also to provide essential evidence for the beneficial use of Spatholobus plants and developing novel health care products and therapeutic drug from this genus.
Collapse
Affiliation(s)
- Yunlu Liu
- Institute of Laboratory Animal Sciences, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan 610212, China.,Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine of University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China.
| | - Qian Xiang
- Healthcare-associated Infection Control Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China
| | - Qi Liang
- College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan 610031, China
| | - Jianyou Shi
- Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine of University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China.
| | - Jun He
- Cancer Center, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
| |
Collapse
|
4
|
Yiğin A, Donmez H, Hitit M, Seven S, Eser N, Kurar E, Seven M. The effect of medicarpin on PTEN/AKT signal pathway in head and neck squamous cell carcinoma. J Cancer Res Ther 2021; 18:180-184. [DOI: 10.4103/jcrt.jcrt_641_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
5
|
Lessons from Exploring Chemical Space and Chemical Diversity of Propolis Components. Int J Mol Sci 2020; 21:ijms21144988. [PMID: 32679731 PMCID: PMC7404124 DOI: 10.3390/ijms21144988] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Revised: 07/13/2020] [Accepted: 07/14/2020] [Indexed: 12/14/2022] Open
Abstract
Propolis is a natural resinous material produced by bees and has been used in folk medicines since ancient times. Due to it possessing a broad spectrum of biological activities, it has gained significant scientific and commercial interest over the last two decades. As a result of searching 122 publications reported up to the end of 2019, we assembled a unique compound database consisting of 578 components isolated from both honey bee propolis and stingless bee propolis, and analyzed the chemical space and chemical diversity of these compounds. The results demonstrated that both honey bee propolis and stingless bee propolis are valuable sources for pharmaceutical and nutraceutical development.
Collapse
|
6
|
Miao YH, Hu YH, Yang J, Liu T, Sun J, Wang XJ. Natural source, bioactivity and synthesis of benzofuran derivatives. RSC Adv 2019; 9:27510-27540. [PMID: 35529241 PMCID: PMC9070854 DOI: 10.1039/c9ra04917g] [Citation(s) in RCA: 127] [Impact Index Per Article: 25.4] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2019] [Accepted: 08/27/2019] [Indexed: 12/30/2022] Open
Abstract
Benzofuran compounds are a class of compounds that are ubiquitous in nature. Numerous studies have shown that most benzofuran compounds have strong biological activities such as anti-tumor, antibacterial, anti-oxidative, and anti-viral activities. Owing to these biological activities and potential applications in many aspects, benzofuran compounds have attracted more and more attention of chemical and pharmaceutical researchers worldwide, making these substances potential natural drug lead compounds. For example, the recently discovered novel macrocyclic benzofuran compound has anti-hepatitis C virus activity and is expected to be an effective therapeutic drug for hepatitis C disease; novel scaffold compounds of benzothiophene and benzofuran have been developed and utilized as anticancer agents. Novel methods for constructing benzofuran rings have been discovered in recent years. A complex benzofuran derivative is constructed by a unique free radical cyclization cascade, which is an excellent method for the synthesis of a series of difficult-to-prepare polycyclic benzofuran compounds. Another benzofuran ring constructed by proton quantum tunneling has not only fewer side reactions, but also high yield, which is conducive to the construction of complex benzofuran ring systems. This review summarizes the recent studies on the various aspects of benzofuran derivatives including their important natural product sources, biological activities and drug prospects, and chemical synthesis, as well as the relationship between the bioactivities and structures.
Collapse
Affiliation(s)
- Yu-Hang Miao
- School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250200 Shandong China
- Institute of Materia Medica, Shandong Academy of Medical Sciences Jinan 250062 Shandong China
- Key Laboratory for Biotech-Drugs Ministry of Health Jinan 250062 Shandong China
- Key Laboratory for Rare & Uncommon Diseases of Shandong Province Jinan 250062 Shandong China
| | - Yu-Heng Hu
- School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250200 Shandong China
- Institute of Materia Medica, Shandong Academy of Medical Sciences Jinan 250062 Shandong China
- Key Laboratory for Biotech-Drugs Ministry of Health Jinan 250062 Shandong China
- Key Laboratory for Rare & Uncommon Diseases of Shandong Province Jinan 250062 Shandong China
| | - Jie Yang
- School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250200 Shandong China
- Institute of Materia Medica, Shandong Academy of Medical Sciences Jinan 250062 Shandong China
- Key Laboratory for Biotech-Drugs Ministry of Health Jinan 250062 Shandong China
- Key Laboratory for Rare & Uncommon Diseases of Shandong Province Jinan 250062 Shandong China
| | - Teng Liu
- School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250200 Shandong China
- Institute of Materia Medica, Shandong Academy of Medical Sciences Jinan 250062 Shandong China
- Key Laboratory for Biotech-Drugs Ministry of Health Jinan 250062 Shandong China
- Key Laboratory for Rare & Uncommon Diseases of Shandong Province Jinan 250062 Shandong China
| | - Jie Sun
- School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250200 Shandong China
- Institute of Materia Medica, Shandong Academy of Medical Sciences Jinan 250062 Shandong China
- Key Laboratory for Biotech-Drugs Ministry of Health Jinan 250062 Shandong China
- Key Laboratory for Rare & Uncommon Diseases of Shandong Province Jinan 250062 Shandong China
| | - Xiao-Jing Wang
- School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250200 Shandong China
- Institute of Materia Medica, Shandong Academy of Medical Sciences Jinan 250062 Shandong China
- Key Laboratory for Biotech-Drugs Ministry of Health Jinan 250062 Shandong China
- Key Laboratory for Rare & Uncommon Diseases of Shandong Province Jinan 250062 Shandong China
| |
Collapse
|
7
|
Development of a Novel Ex-vivo 3D Model to Screen Amoebicidal Activity on Infected Tissue. Sci Rep 2019; 9:8396. [PMID: 31182753 PMCID: PMC6557822 DOI: 10.1038/s41598-019-44899-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2018] [Accepted: 05/28/2019] [Indexed: 01/12/2023] Open
Abstract
Amoebiasis is a parasitic disease that causes thousands of deaths every year, its adverse effects and resistance to conventional treatments have led to the search of new treatment options, as well as the development of novel screening methods. In this work, we implemented a 3D model of intestine and liver slices from hamsters that were infected ex vivo with virulent E. histolytica trophozoites. Results show preserved histology in both uninfected tissues as well as ulcerations, destruction of the epithelial cells, and inflammatory reaction in intestine slices and formation of micro abscesses, and the presence of amoebae in the sinusoidal spaces and in the interior of central veins in liver slices. The three chemically synthetized compounds T-001, T-011, and T-016, which act as amoebicides in vitro, were active in both infected tissues, as they decreased the number of trophozoites, and provoked death by disintegration of the amoeba, similar to metronidazole. However, compound T-011 induced signs of cytotoxicity to liver slices. Our results suggest that ex vivo cultures of precision-cut intestinal and liver slices represent a reliable 3D approach to evaluate novel amoebicidal compounds, and to simultaneously detect their toxicity, while reducing the number of experimental animals commonly required by other model systems.
Collapse
|
8
|
Wang HY, Li T, Ji R, Xu F, Liu GX, Li YL, Shang MY, Cai SQ. Metabolites of Medicarpin and Their Distributions in Rats. Molecules 2019; 24:molecules24101966. [PMID: 31121832 PMCID: PMC6572127 DOI: 10.3390/molecules24101966] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Revised: 05/11/2019] [Accepted: 05/18/2019] [Indexed: 12/20/2022] Open
Abstract
Medicarpin is a bioactive pterocarpan that has been attracting increasing attention in recent years. However, its metabolic fate in vivo is still unknown. To clarify its metabolism and the distribution of its metabolites in rats after oral administration, the HPLC-ESI-IT-TOF-MSn technique was used. A total of 165 new metabolites (13 phase I and 152 phase II metabolites) were tentatively identified, and 104, 29, 38, 41, 74, 28, 24, 15, 42, 8, 10, 3, and 17 metabolites were identified in urine, feces, plasma, the colon, intestine, stomach, liver, spleen, kidney, lung, heart, brain, and thymus, respectively. Metabolic reactions included demethylation, hydrogenation, hydroxylation, glucuronidation, sulfation, methylation, glycosylation, and vitamin C conjugation. M1 (medicarpin glucuronide), M5 (vestitol-1'-O-glucuronide) were distributed to 10 organs, and M1 was the most abundant metabolite in seven organs. Moreover, we found that isomerization of medicarpin must occur in vivo. At least 93 metabolites were regarded as potential new compounds by retrieving information from the Scifinder database. This is the first detailed report on the metabolism of ptercarpans in animals, which will help to deepen the understanding of the metabolism characteristics of medicarpin in vivo and provide a solid basis for further studies on the metabolism of other pterocarpans in animals.
Collapse
Affiliation(s)
- Hong-Yan Wang
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
| | - Teng Li
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
| | - Rui Ji
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
- School of Pharmacy, Heilongjiang University of Chinese Medicine, No.24, Heping Road, Xiangfang District, Harbin 150040, China.
| | - Feng Xu
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
| | - Guang-Xue Liu
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
| | - Yao-Li Li
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
| | - Ming-Ying Shang
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
| | - Shao-Qing Cai
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China.
| |
Collapse
|